Are BTK and PLCG2 mutations essential and ample for ibrutinib resistance in Serious lymphocytic leukemia? Deep, focused next-era sequencing has disclosed that subclonal mutations (i.e., All those current in just a portion of tumor cells) could be detected for all driver genes and they are connected to speedy disease development https://charlesc075ucm2.nizarblog.com/profile